Anticardiolipin and anti‐beta 2‐glycoprotein I antibodies in patients with unexplained articular manifestations
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Clinical Laboratory Analysis"
DOI: 10.1002/jcla.24812
Abstract: To determine the frequency of antiphospholipid antibodies (aPL) in patients with unexplained articular manifestations. read more here.
Keywords: articular manifestations; unexplained articular; anticardiolipin anti; patients unexplained ... See more keywords
Cross-reactivity between annexin A2 and Beta-2-glycoprotein I in animal models of antiphospholipid syndrome
Sign Up to like & getrecommendations! Published in 2017 at "Immunologic Research"
DOI: 10.1007/s12026-016-8840-8
Abstract: Antiphospholipid syndrome (APS) affects coagulation and the brain by autoimmune mechanisms. The major antigen in APS is beta-2-glycoprotein I (β2-GPI) is known to complex with annexin A2 (ANXA2), and antibodies to ANXA2 have been described… read more here.
Keywords: antiphospholipid syndrome; anxa2 antibodies; annexin; beta glycoprotein ... See more keywords
Anti-beta 2 glycoprotein I IgA in the SLICC classification criteria dataset
Sign Up to like & getrecommendations! Published in 2021 at "Lupus"
DOI: 10.1177/09612033211014248
Abstract: Objective Anti-beta 2 glycoprotein I IgA is a common isotype of anti-beta 2 glycoprotein I in SLE. Anti-beta 2 glycoprotein I was not included in the American College of Rheumatology (ACR) SLE classification criteria, but… read more here.
Keywords: anti beta; glycoprotein iga; beta glycoprotein;
A systematic review of the association between anti-beta-2 glycoprotein I antibodies and APS manifestations.
Sign Up to like & getrecommendations! Published in 2021 at "Blood advances"
DOI: 10.1182/bloodadvances.2021005205
Abstract: Anti-beta-2 glycoprotein I antibodies (anti-B2GPI) are often cited as the major pathogenically relevant antibody in antiphospholipid syndrome (APS), but it is unclear if there is clinical evidence to support this theory. We performed a systematic… read more here.
Keywords: systematic review; beta glycoprotein; association; anti b2gpi ... See more keywords
Beta-2-glycoprotein I as a biomarker for sepsis in critically ill patients in the intensive care unit: a prospective cohort study
Sign Up to like & getrecommendations! Published in 2020 at "Critical Care"
DOI: 10.1186/s13054-020-03066-3
Abstract: No abstract available Keywords: Apolipoprotein H; B2GPI; Biomarkers; Critical care; ICU; SIRS; Sepsis. read more here.
Keywords: sepsis; sepsis critically; biomarker sepsis; beta glycoprotein ... See more keywords
Antiphospholipid Antibodies to Domain I of Beta-2-Glycoprotein I Show Different Subclass Predominance in Comparison to Antibodies to Whole Beta-2-glycoprotein I
Sign Up to like & getrecommendations! Published in 2018 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2018.02244
Abstract: Antiphospholipid antibodies (aPL), the serological hallmark of antiphospholipid syndrome (APS), are a heterogeneous group of autoantibodies raised against circulating blood proteins. Of these proteins, the phospholipid-binding b2-glycoprotein I (β2GPI) is considered to be the main… read more here.
Keywords: igg; adi; beta glycoprotein; subclass ... See more keywords
PEGylated Domain I of Beta-2-Glycoprotein I Inhibits the Binding, Coagulopathic, and Thrombogenic Properties of IgG From Patients With the Antiphospholipid Syndrome
Sign Up to like & getrecommendations! Published in 2018 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2018.02413
Abstract: APS is an autoimmune disease in which antiphospholipid antibodies (aPL) cause vascular thrombosis and pregnancy morbidity. In patients with APS, aPL exert pathogenic actions by binding serum beta-2-glycoprotein I (β2GPI) via its N-terminal domain I… read more here.
Keywords: pegylated domain; domain beta; beta glycoprotein; beta ... See more keywords
PEGylated Domain I of Beta-2-Glycoprotein I Inhibits Thrombosis in a Chronic Mouse Model of the Antiphospholipid Syndrome
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.842923
Abstract: Antiphospholipid syndrome (APS) is an autoimmune disorder in which autoantibodies cause clinical effects of vascular thrombosis and pregnancy morbidity. The only evidence-based treatments are anticoagulant medications such as warfarin and heparin. These medications have a… read more here.
Keywords: beta glycoprotein; thrombosis; mouse model; model ... See more keywords